Outcomes of transcatheter aortic valve implantation in patients with chronic and end-stage kidney disease
The American Journal of Cardiology Dec 01, 2021
Hahn J, Ul Hassan Virk H, Greason K, et al. - Findings demonstrate independent associations of both atrial fibrillation (AF) and mitral stenosis (MS) with increased mortality in chronic kidney disease (CKD) patients undergoing transcatheter aortic valve implantation (TAVI).
A higher risk of aortic stenosis has been noted in patients with CKD and end-stage kidney disease (ESKD) and there exists limited data on TAVI in these patients.
From a large urban healthcare system, clinical data of patients with ESKD (n=84) and CKD (n=643) who had TAVI from 2008 to 2018 were analyzed.
The overall in-hospital mortality in CKD group was 5.1% and those with ESKD had an overall mortality rate of 11.9%.
Post-multivariable analysis, independent links of both MS (adjusted odds ratio (OR) 3.92) and AF (adjusted OR 2.42) with mortality were identified in CKD patients.
A link, albeit not statistically significant, was observed between MS and increased mortality in ESKD patients (adjusted OR 2.01).
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries